Therapeutic Targeting of Lewisy and Lewisb with a Novel Monoclonal Antibody 692/29
Figure 2
Binding of anti-Lewisy and Lewisb mAbs to a panel of tumour cell lines.
A range of cancer cell lines were stained by indirect immunofluorescence with mAbs 692/29, BR96 and 2-25 LE and analysed by flow cytometry. An IgG isotype control was used as a negative control. This assay was repeated 6 times and one representative result is shown.